Actively Recruiting
Evaluating Heart Rate Variability to Guide Oxygen Flow Settings During High-Flow Nasal Cannula Therapy for Respiratory Failure
Led by University Health Network, Toronto · Updated on 2026-06-18
20
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to explore how heart rate variability HRV can be used as a marker to guide the adjustment of oxygen flow rates during high-flow nasal cannula HFNC therapy in patients with respiratory failure. HFNC provides non-invasive respiratory support by delivering high oxygen flow to ease breathing, but the optimal way to adjust flow rates is not well established. The study focuses on whether HRV changes earlier than traditional respiratory signs when respiratory function varies due to inadequate oxygen flow. Participants already receiving HFNC therapy as part of standard care will have their oxygen flow reduced stepwise from 60 Lmin to 20 Lmin. During this process, continuous monitoring with electrocardiogram ECG and electrical impedance tomography EIT will be performed. Oxygen concentration FiO2 will be adjusted to keep blood oxygen saturation above 90%. Respiratory measures including tidal volume, respiratory rate, and oxygen levels will be recorded alongside HRV analysis from ECG data. Participants will be observed throughout the flow reduction period lasting up to 1 hour and 45 minutes. Researchers will collect heart rate variability, respiratory parameters, and compare HRV data from pulse oximetry and ECG. The study aims to determine if HRV is a sensitive tool for optimizing HFNC flow settings to prevent respiratory deterioration and improve patient care. The total participation time corresponds to the duration of the flow titration procedure.
CONDITIONS
Brief Title
Heart Rate VAriability as a MaRker for tItrATing hIgh flOw Nasal Cannula Therapy
Research Team
R
Rongyu (Cindy) Jin
M
Marcela Amaral
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here